Kurs
-2,53%
Kurs
-2,53%
Kalender
Est. tid* | ||
2025-10-31 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-07-11 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-04-30 | - | Kvartalsrapport 2025-Q1 |
2025-04-28 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
2025-04-25 | - | Årsstämma |
2025-02-12 | - | Bokslutskommuniké 2024 |
2024-11-01 | - | Kvartalsrapport 2024-Q3 |
2024-09-09 | - | X-dag ordinarie utdelning AKBM 45.00 NOK |
2024-09-03 | - | Extra Bolagsstämma 2024 |
2024-07-12 | - | Kvartalsrapport 2024-Q2 |
2024-04-26 | - | Kvartalsrapport 2024-Q1 |
2024-04-17 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
2024-04-16 | - | Årsstämma |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-11-01 | - | Kvartalsrapport 2023-Q3 |
2023-07-14 | - | Kvartalsrapport 2023-Q2 |
2023-04-28 | - | Kvartalsrapport 2023-Q1 |
2023-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
2023-04-20 | - | Årsstämma |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-01 | - | Kvartalsrapport 2022-Q3 |
2022-07-14 | - | Kvartalsrapport 2022-Q2 |
2022-04-29 | - | Kvartalsrapport 2022-Q1 |
2022-04-21 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
2022-04-20 | - | Årsstämma |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-29 | - | Kvartalsrapport 2021-Q3 |
2021-07-14 | - | Kvartalsrapport 2021-Q2 |
2021-04-29 | - | Kvartalsrapport 2021-Q1 |
2021-03-15 | - | X-dag ordinarie utdelning AKBM 0.00 NOK |
2021-03-12 | - | Årsstämma |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-10-30 | - | Kvartalsrapport 2020-Q3 |
2020-07-15 | - | Kvartalsrapport 2020-Q2 |
Beskrivning
Land | Norge |
---|---|
Lista | Oslo Bors |
Sektor | Handel & varor |
Industri | Dagligvaror |
2023-02-17 17:10:09
AS Kanalmontasje, a close associate of Ola Snøve, Chairman of the Board in Aker
BioMarine ASA, has today purchased 46,379 shares in Aker BioMarine ASA at an
average price of NOK 39.94 per share. Following the transaction, Mr. Snøve and
his close associates control 858,619 shares in Aker BioMarine ASA.
Please see attached primary insider notification form pursuant to the
requirements of the Market Abuse Regulation ("MAR").
This information is subject to the disclosure requirements pursuant to MAR
Article 19 and Section 5-12 of the Norwegian Securities Trading Act.